PolarX sees potential to expand resource


Published 20-JAN-2020 11:18 A.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

PolarX Limited (ASX:PXX) has released promising trenching, mapping and sampling results that demonstrate the potential for approximately 600 metres of mineralised strike length at the Zackly East skarn within its Alaska Range Project.

As shown below, diamond drill holes ZX‐18020 (55 metres at 2.8g/t gold and 0.6% copper) and ZX‐18024 (47 metres at 3.1g/t gold and 0.6% copper) intersected thick copper and gold mineralisation commencing from near surface at Zackly East in 2018.

These results highlight the scope for significant growth in the existing Zackly Inferred Resource of 41,000 tonnes copper, 213,000 ounces gold and 1.5 million ounces silver from surface.

The Zackly Skarn sits within the Alaska Range project, which also hosts the Mars porphyry copper‐gold discovery and the large Saturn porphyry target.

There is also potential for near‐surface resource extensions and multiple mineralised skarn positions further along the 12 kilometres long Mars‐Zackly‐Saturn structural corridor.

The Main Skarn and East Skarn lie within the Structural Corridor that runs west‐east from the Mars porphyry discovery through Zackly and to the northern edge of the Saturn porphyry target as indicated below.

This corridor contains many untested magnetic and structural targets and has the potential to host multiple additional skarn deposits, as well as larger porphyry copper deposits.

Drilling to confirm the extension of the Zackly East skarn should be conducted around mid-year.

Discussions are underway with several parties which have expressed interest in pursuing the porphyry targets at Mars and Saturn via an earn‐in joint venture.

Potential to expand resource

Importantly, the thick, near‐surface nature of mineralisation in holes ZX‐18020 and ZX‐18024, as well as ZX‐18021, combined with the new information suggests considerable strike‐length/extensions.

This may allow rapid accumulation of additional resource tonnes and metal inventory through further drilling.

Surface copper mineralisation identified

Rock type, bedding direction, mineralisation, veining and fault controls on mineralisation are all consistent across trenches 1 and 2 as shown in the first diagram.

From a geological perspective, copper mineralisation was observed to be related to moderately to steeply dipping north-west to south-east trending faults that cut across the andesite rocks and clearly post‐dating the thrust emplacement.

The following diagram shows strong surface copper mineralisation discovered in rock‐chip samples collected along the trenches.

As indicated above, impressive copper assay results were obtained from both trenches.

Trench 1 contained two mineralised zones with 16 metres 509 ppm copper and 20 metres at 566 ppm copper.

Trench 2 had one strongly mineralised zone with 14 metres at 1265 ppm copper.

These are considered significant assays for trenches that are situated in the overlying volcanic rocks, namely those that are above the underlying limestone/skarn.

Possible share price catalysts in 2020 include confirmation of a joint-venture agreement in relation to pursuing porphyry targets at Mars and Saturn, mid-year drilling results and resource expansion with the most likely near term news driver being a joint-venture proposal.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free